Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China

MeSH terms

• Adalimumab* / therapeutic use
• Adult
• Antirheumatic Agents / therapeutic use
• Axial Spondyloarthritis* / diagnosis
• Axial Spondyloarthritis* / drug therapy
• Axial Spondyloarthritis* / immunology
• Biosimilar Pharmaceuticals* / adverse effects
• Biosimilar Pharmaceuticals* / therapeutic use
• China / epidemiology
• Female
• Humans
• Male
• Middle Aged
• Retrospective Studies
• Treatment Outcome
• Tumor Necrosis Factor Inhibitors / adverse effects
• Tumor Necrosis Factor Inhibitors / therapeutic use